Ameriprise Financial Inc Abb Vie Inc. Transaction History

Ameriprise Financial Inc

$388 Billion
Q2 2025

A detailed history of Ameriprise Financial Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 9,267,451 shares of ABBV stock, worth $1.84 Billion. This represents 0.44% of its overall portfolio holdings.

Number of Shares

9,267,451

Previous 12,395,341 25.23%

Holding current value

$1.84 Billion

Previous $2.6 Billion 33.76%

% of portfolio

0.44%

Previous 0.73%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$170.16 - $206.27 $532 Million - $645 Million	-3,127,890 Reduced 25.23%	9,267,451 $1.72 Billion
Q1 2025 May 14, 2025	SELL	$169.2 - $216.66 $107 Million - $138 Million	-635,327 Reduced 4.88%	12,395,341 $2.6 Billion
Q4 2024 Feb 14, 2025	SELL	$164.99 - $203.87 $134 Million - $165 Million	-809,440 Reduced 5.85%	13,030,668 $2.32 Billion
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $34.3 Million - $41.8 Million	-209,515 Reduced 1.49%	13,840,108 $2.73 Billion
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $23.9 Million - $27.9 Million	-154,584 Reduced 1.09%	14,049,623 $2.41 Billion
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1.93 Million - $2.2 Million	12,090 Added 0.09%	14,204,207 $2.59 Billion
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $17.3 Million - $19.5 Million	126,035 Added 0.9%	14,192,117 $2.2 Billion
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $26.7 Million - $30.9 Million	199,833 Added 1.44%	14,066,082 $2.1 Billion
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $113 Million - $140 Million	-851,539 Reduced 5.79%	13,866,249 $1.87 Billion
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $212 Million - $244 Million	1,463,681 Added 11.04%	14,717,788 $2.35 Billion
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $31 Million - $37.2 Million	224,116 Added 1.72%	13,254,107 $2.14 Billion
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $10.2 Million - $11.7 Million	75,787 Added 0.59%	13,029,991 $1.75 Billion
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $6.48 Million - $8.24 Million	47,114 Added 0.37%	12,954,204 $1.98 Billion
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $29.4 Million - $36.5 Million	-223,127 Reduced 1.7%	12,907,090 $2.09 Billion
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $286 Million - $362 Million	2,665,628 Added 25.47%	13,130,217 $1.77 Billion
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $302 Million - $343 Million	2,842,328 Added 37.29%	10,464,589 $1.13 Billion
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $82.7 Million - $92.1 Million	-786,065 Reduced 9.35%	7,622,261 $858 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $23.4 Million - $25.7 Million	228,338 Added 2.79%	8,408,326 $911 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $17 Million - $23 Million	211,677 Added 2.66%	8,179,988 $877 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $5.39 Million - $6.32 Million	-62,686 Reduced 0.78%	7,968,311 $697 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $51.8 Million - $69.3 Million	705,784 Added 9.63%	8,030,997 $789 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $61 Million - $92.5 Million	945,863 Added 14.83%	7,325,213 $558 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $2.31 Million - $2.89 Million	-31,981 Reduced 0.5%	6,379,350 $565 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $168 Million - $202 Million	2,664,786 Added 71.13%	6,411,331 $491 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $26.8 Million - $34.3 Million	407,876 Added 12.22%	3,746,545 $271 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $24.4 Million - $28.8 Million	-316,939 Reduced 8.67%	3,338,669 $268 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $10.1 Million - $12.4 Million	129,270 Added 3.67%	3,655,608 $338 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $75.1 Million - $83.5 Million	844,429 Added 31.49%	3,526,338 $547 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $199 Million - $235 Million	-2,216,636 Reduced 45.25%	2,681,909 $248 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $146 Million - $195 Million	-1,581,602 Reduced 24.41%	4,898,545 $464 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $68.9 Million - $75.6 Million	-769,441 Reduced 10.61%	6,480,147 $627 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $506 Million - $647 Million	7,249,588	7,249,588 $647 Million

Others Institutions Holding ABBV

# of Institutions

4,255

Shares Held

1.28B

Call Options Held

16.1M

Put Options Held

14.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $351B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Abb Vie Inc. Transaction History